Critical Conversations in Advanced RCC: Guidance on Immunotherapy and Immunotherapy-Based Combinations

This program aims to improve learners’ knowledge, confidence, and competence in integrating the latest clinical guidance, practice-changing data, and expert recommendations on immunotherapy and immunotherapy-based combinations in advanced/metastatic RCC.

Share

Program Content

Activities

Immunotherapy combinations in Advanced RCC
Advanced Renal Cell Carcinoma: Immunotherapy and Immunotherapy-Based Combinations
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 07, 2023

View Activity

Activities

Critical Conversations in Advanced RCC
Critical Conversations in Advanced RCC: Guidance on Immunotherapy and Immunotherapy-Based Combinations
Video
Congratulations: You achieved a completion on 04/09/2022

Released: June 22, 2023

Expires: June 21, 2024

View Activity

Activities

RCC FAQs
Advanced Renal Cell Carcinoma: Experts Answer Your Questions
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 14, 2023

View Activity

Faculty

cover img faculity

Eric Jonasch, MD

Professor, Department of GU Medical Oncology
The University of Texas
MD Anderson Cancer Center
Houston, Texas

cover img faculity

Brian Rini, MD, FASCO

Chief of Clinical Trials 
Division of Hematology/Oncology 
Vanderbilt University Medical Center
Nashville, Tennesee 

cover img faculity

Tian Zhang, MD, MHS

Associate Professor
Genitourinary Oncology and Multi-Disease Precision Oncology Programs
Division of Hematology and Oncology
Department of Internal Medicine
UT Southwestern Medical Center
Harold C. Simmons Comprehensive Cancer Center
Dallas, Texas

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb